Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian
‘The romance of football is cremated’ : the clubs charging kids to be mascots
5/11/2025
Danish authorities in rush to close security loophole in Chinese electric buses
5/11/2025
‘I’m never surprised when I read about a woman murdering a man’ : Helen Garner on her Baillie Gifford prize-winning diaries
5/11/2025
Japan deploys soldiers to contain surge in bear attacks in Akita
5/11/2025
The Marbles review – thoughtful outline of case for giving the Parthenon marbles back to Greece
5/11/2025
How to turn the dregs of a tin of golden syrup into a delectable toffee sauce – recipe | Waste not
5/11/2025